NOS3 and angioedema: While drug-associated angioedema typically manifests through either bradykinin-mediated or mast cell-mediated pathways [34], amlodipine’s mechanism appears to involve endothelial nitric oxide synthase (eNOS) activation, leading to nitric oxide production that can be antagonized by icatibant, a bradykinin-receptor antagonist [35].